100% of Net Proceeds fund Research

you_donate
Every single net penny you give... (no overhead, no administrative fees)
four_hearts
clinical_trials
Goes directly to clinical trials and research
6_pink_hearts
children_chance_for_life
Giving our children a “Chance for Life”

Thank you for your interest in giving all children a Chance for Life. We are proud to fund research that drives new, innovative treatments for Pediatric Cancers especially in the area of pediatric neuro-oncology. The 2022 Chance for Life LOI process will begin accepting applications on September 24 for an LOI submission period between September 24 and February 4, 2022.

Chance for Life (CFL) welcomes proposals from researchers within the United States of America working on pediatric cancer initiatives.

Requests up to $150,000 will be considered.

In past funding rounds, CFL has funded projects that have focused on the following:

 

  1. The basis of tumor initiation and progression
  2. Novel therapeutic approaches
  3. Development of novel biomarkers or methodologies to predict disease progression and to enhance efforts in primary and secondary prevention and intervention
  4. Novel models that would enhance pre-clinical research
  5. Development of more effective, less-invasive and/or less toxic treatments to improve long-term health and quality of life.

 

The CFL application process will take place in two phases:

Phase 1: Submission of Letters of Interest (LOI)

Phase 2: Submission of Full Application upon invitation.

 

The 2021 funding opportunity will primarily support pediatric oncology research initiatives over a 12 or 18-month timeframe.

 

Application Deadlines:
February 4, 2022LOIs due
March 1, 2022Notification of advancement to full proposals
April 4, 2022Full applications due
June 10, 2022Funded organizations notified

 

Key Funding Notes:

CFL encourages collaborative, multi-disciplinary, multi-institutional research with efforts to achieve insight and innovation with the following priorities:

  • Traditionally, CFL has funded on pediatric neuro-oncology research initiatives, however, CFL is extending the focus to include proposals addressing pediatric osteosarcomas during the 2022 funding cycle.
  • Focused, outcome-oriented and innovative pediatric cancer research initiatives are preferred.
  • Funding will be allocated to research activities taking place in the United States of America.
  • CFL welcomes the opportunity to be the sole source of funding.

 

LOI Questions:



    words. Please limit to 500 words or less.
    (Download NIH standard biosketch format to complete)

    Please click here to complete a Brand Licensing Pre-Approval Agreement. Completing this agreement is a requirement for funding approval.

    Get our updates by email

    We'll never share your email address and you can opt out at any time, we promise.